FDA — authorised 26 February 2001
- Application: NDA021235
- Marketing authorisation holder: LILLY
- Local brand name: PROZAC WEEKLY
- Indication: CAPSULE, DELAYED REL PELLETS — ORAL
- Status: approved
🇺🇸 PROZAC WEEKLY® in United States
FDA authorised PROZAC WEEKLY® on 26 February 2001
Marketing authorisation
Frequently asked questions
Is PROZAC WEEKLY® approved in United States?
Yes. FDA authorised it on 26 February 2001.
Who is the marketing authorisation holder for PROZAC WEEKLY® in United States?
LILLY holds the US marketing authorisation.